MetroWest

Framingham native and resident Vaios Theodorakos, who bought the much-neglected Arcade Block two years ago, is looking to add 24 apartments to the property's Amsden Building, at 95-115 Concord St. The apartments will be above Limey's Pub, he said, offering a residential component to the planned mixed-use development.

The parent group of Lonza Biologics will lay off most of its approximately 300 workers at its Hopkinton plant this year and gradually reduce operations there as part of cost reductions by the Switzerland-based pharmaceutical supplier.

McKesson Medical-Surgical recently renewed its Northborough lease and expanded by nearly 50,000 square feet, according to a broker involved in the deal.

Natick-based Boston Scientific Corp. saw improvement over last year in its second quarter, with a net income of $130 million, compared with a loss of $3.6 billion in 2012, the company announced today.

EMC Corp. of Hopkinton reported a record second quarter in revenue and net earnings that matched analysts' expectations.

Framingham's prominent Bullard Building has been purchased for $1.3 million.

Milford-based Waters Corp. saw generally flat financial figures for its 2013 second quarter, compared with last year, the company reported today.

Berkshire Hills Bancorp announced updated guidance ahead of the release of its second-quarter earnings on Wednesday.

Westborough-based RXi Pharmaceuticals Corp., a clinical-phase biotechnology company focusing on RNA-target technology, has filed an application for listing on The NASDAQ Capital Market.

We recently collaborated with Framingham State University and the 495/MetroWest Partnership to conduct a survey that asked area business leaders to weigh in on the health of the area economy. The results are in, and the highlights will be published in a special edition of MetroWest495 Biz that will be published August 12. Be sure to read this upcoming issue to learn what the business community had to say about economic conditions and the outlook for the year ahead.